Impacts of Pharmaceutical Pollution on Communities and Environment in India
As part of our engagement with pharmaceutical companies and their supply chain management in India and a follow-up to the video about Nordea’s visit to Hyderabad and Visakhapatnam in April 2015, we commissioned an on-the-ground investigation in Hyderabad and Visakhaptanam in early 2016. The resulting report documents and show local impacts of drug pollution and severe contamination of waterways and agricultural lands. Again, the evidence shows that the situation is very serious. The effluent treatments systems set up are inefficient and there is systematic dumping of chemical effluent in rivers, lakes and groundwater by the pharmaceutical sector.
The report draws links between polluting manufacturers and some of the large multinational pharmaceutical companies they have dealings with. But the report also concludes that the lack of transparency in pharmaceutical supply chains makes it almost impossible to map the journey of a pharmaceutical product from factory to pharmacy shelf.
We will continue our dialogue with the pharmaceutical companies.
Download the report here (pdf, 10 MB).
Other Responsible investment news
Field visits Responsible business
In March Nordea’s Sasja Beslik visited Inrego, one of our corporate customers. He went to Inrego’s factory in Stockholm to learn more about their circular b...
Our people Responsible investment Sustainability
Europe must become the global hub for sustainable investment – and Nordea is ready to help Europe bring sustainable finance into the mainstream. These are s...
Responsible investment Society
CFA Sweden awards The Corporate Human Rights Benchmark (CHEB), of which Nordea is a funding member.
Sustainability Reports and data Responsible investment
The increasing demand for rare earth metals is bringing new risks.
Sustainability Our work
Nordea ranked as one of the top sustainable corporations in the world.